A new WTW survey reveals that over half of employers exceeded their healthcare budgets in 2024 and expect rising costs to continue, prompting a shift toward cost-containment strategies, vendor ...
Pfizer’s internal obesity drug R&D stumbled, but the pharmaceutical giant is leaping ahead in this field through the multi-billion dollar acquisition of Metsera, a clinical-stage company whose ...
A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...
The U.S. Food & Drug Administration (FDA) recently removed its Risk Evaluation and Mitigation Strategies (REMS) designation from CAR T immunotherapies. REMS is occasionally applied to drugs with ...
AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention — are gaining traction in the healthcare world. The industry is under massive pressure ...
From left to right: Keith J. Figlioli, managing partner at LRVHealth; Dr. Steve Miff, president and CEO of Parkland Center for Clinical Innovation AI is becoming an essential part of the healthcare ...
In rural America, virtual care often means the difference between care and no care. Few people know this to be true more than Dave Newman, chief medical officer of virtual care at Sanford Health. For ...
As artificial intelligence becomes a buzzword in nearly every healthcare startup pitch, investors are finding it increasingly challenging to distinguish which ones are actually worth the hype. That’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback